Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 55 results.
User Information
Export Records
  1. 1.   Chemically Programmable and Switchable CAR-T Therapy
  2. Qi, Junpeng; Tsuji, Kohei; Hymel, David; Burke,Terrence; Hudecek, Michael; Rader, Christoph; Peng, Haiyong
  3. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 2020, MAY 18;
  1. 2.   Loss of tetherin antagonism by Nef impairs SIV replication during acute infection of rhesus macaques
  2. Tavakoli-Tameh, Aidin; Janaka, Sanath Kumar; Zarbock, Katie; O'Connor, Shelby; Crosno, Kristin; Capuano, Saverio; Uno, Hajime; Lifson,Jeffrey; Evans, David T
  3. PLoS pathogens. 2020, Apr 17; 16(4): e1008487.
  1. 3.   Evidence of a Role for Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor (SNARE) Machinery in HIV-1 Assembly and Release
  2. Joshi, A.; Garg, H.; Ablan, S. D.; Freed, E. O.
  3. Journal of Biological Chemistry. 2011, Aug; 286(34): 29861-29871.
  1. 4.   Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor
  2. Xiao, X. D.; Feng, Y.; Zhu, Z. Y.; Dimitrov, D. S.
  3. Biochemical and Biophysical Research Communications. 2011, Jul; 411(2): 253-258.
  1. 5.   Unconventional Secretion of Tissue Transglutaminase Involves Phospholipid-Dependent Delivery into Recycling Endosomes
  2. Zemskov, E. A.; Mikhailenko, I.; Hsia, R. C.; Zaritskaya, L.; Belkin, A. M.
  3. Plos One. 2011, Apr; 6(4): 14.
  1. 6.   Opposing Effects of a Tyrosine-Based Sorting Motif and a PDZ-Binding Motif Regulate Human T-Lymphotropic Virus Type 1 Envelope Trafficking
  2. Ilinskaya, A.; Heidecker, G.; Derse, D.
  3. Journal of Virology. 2010, Jul; 84(14): 6995-7004.
  1. 7.   The Path Well Traveled: Using Mammalian Retroviruses to Guide Research on XMRV
  2. Lee, K.; Jones, K. S.
  3. Molecular Interventions. 2010, Feb; 10(1): 20-24.
  1. 8.   Assembly and intracellular trafficking of HLA-B*3501 and HLA-B*3503
  2. Thammavongsa, V.; Schaefer, M.; Filzen, T.; Collins, K. L.; Carrington, M.; Bangia, N.; Raghavan, M.
  3. Immunogenetics. 2009, Dec; 61(11-12): 703-716.
  1. 9.   Structure and Function of beta-1,4-Galactosyltransferase
  2. Qasba, P. K.; Ramakrishnan, B.; Boeggeman, E.
  3. Current Drug Targets. 2008 9(4): 292-309.
  1. 10.   Inhibition of HIV-1 replication by amphotericin B methyl ester - Selection for resistant variants
  2. Waheed, A. A.; Ablan, S. D.; Mankowski, M. K.; Cummins, J. E.; Ptak, R. G.; Schaffner, C. P.; Freed, E. O.
  3. Journal of Biological Chemistry. 2006, Sep; 281(39): 28699-28711.
  1. 11.   Immunogenicity testing of a novel engineered HIV-1 envelope Gp140 DNA vaccine construct
  2. Kumar, S.; Yan, J.; Muthumani, K.; Ramanathan, M. P.; Yoon, H.; Pavlakis, G. N.; Felber, B. K.; Sidhu, M.; Boyer, J. D.; Weiner, D. B.
  3. DNA and Cell Biology. 2006, Jul; 25(7): 383-392.
  1. 12.   Development of a quantitative cell-based ELISA, for a humanized anti-IL-2/IL-15 receptor beta antibody (HuMik beta(1)), and correlation with functional activity using an antigen-transfected murine cell line
  2. Yang, X. Y.; Chen, E.; Jiang, H. G.; Hartmann, W. K.; Mitra, G.; Hecht, T.; Soman, G.
  3. Journal of Immunological Methods. 2006, APR 20; 311(1-2): 71-80.
  1. 13.   HTLV-1 Gag protein associates with CD82 tetraspanin microdomains at the plasma membrane
  2. Mazurov, D.; Heidecker, G.; Derse, D.
  3. Virology. 2006, MAR 1; 346(1): 194-204.
  1. 14.   Fenretinide inhibits HIV infection by promoting viral endocytosis
  2. Finnegan, C. M.; Blumenthal, R.
  3. Antiviral Research. 2006, Feb; 69(2): 116-123.
  1. 15.   Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRI
  2. Qasba, P. K.; Ramakrishnan, B.; Boeggeman, E.
  3. Aaps Journal. 2006 8(1): E190-E195.
  1. 16.   Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: From simple paradigms to complex mechanisms
  2. Grivennikov, S. I.; Kuprash, D. V.; Liu, Z. G.; Nedospasov, S. A.
  3. International Review of Cytology - a Survey of Cell Biology, Vol 252. 2006; 252 : 129-+.
  1. 17.   Structure of a V3-containing HIV-1 gp120 core
  2. Huang, C. C.; Tang, M.; Zhang, M. Y.; Majeed, S.; Montabana, E.; Stanfield, R. L.; Dimitrov, D. S.; Korber, B.; Sodroski, J.; Wilson, I. A.; Wyatt, R.; Kwong, P. D.
  3. Science. 2005, NOV 11; 310(5750): 1025-1028.
  1. 18.   Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail
  2. Wyss, S.; Dimitrov, A. S.; Baribaud, F.; Edwards, T. G.; Blumenthal, R.; Hoxie, J. A.
  3. Journal of Virology. 2005, OCT; 79(19): 12231-12241.
  1. 19.   Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virus
  2. Yuste, E.; Johnson, W.; Pavlakis, G. N.; Desrosiers, R. C.
  3. Journal of Virology. 2005, OCT; 79(19): 12455-12463.
  1. 20.   Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5
  2. Dong, H. F.; Wigmore, K.; Carrington, M. N.; Dean, M.; Turpin, J. A.; Howard, O. M. Z.
  3. Genes and Immunity. 2005, OCT; 6(7): 609-619.
  1. 21.   Whole cell segmentation in solid tissue sections
  2. Baggett, D.; Nakaya, M. A.; McAuliffe, M.; Yamaguchi, T. P.; Lockett, S.
  3. Cytometry Part A. 2005, OCT; 67A(2): 137-143.
  1. 22.   Amino acid residues that are important for Hyal2 function as a receptor for jaagsiekte sheep retrovirus
  2. Duh, F. M.; Dirks, C.; Lerman, M. I.; Miller, A. D.
  3. Retrovirology. 2005, Sep; 2
  1. 23.   Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity
  2. Carlos, C. A.; Dong, H. F.; Howard, O. M. Z.; Oppenheim, J. J.; Hanisch, F. G.; Finn, O. J.
  3. Journal of Immunology. 2005, AUG 1; 175(3): 1628-1635.
  1. 24.   Cell surface GLUT-1 overexpression enhances cell-cell transmission of HTLV-I virions
  2. Fugo, K.; Takenouchi, N.; Yao, K.; Lisinski, I.; Cushman, S. W.; Ruscetti, F. W.; Jones, K.; Jacobson, S.
  3. Aids Research and Human Retroviruses. 2005, MAY; 21(5): 506, Abstract P150-506, Abstract P150.
  1. 25.   Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis
  2. Brooks, A. D.; Sayers, T. J.
  3. Cancer Immunology Immunotherapy. 2005, MAY; 54(5): 499-505.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel